Long-term efficacy of ustekinumab with and without concomitant immunosuppressants for Crohn's disease: results from IM-UNITI long-term extension through 2 years

被引：2
|
作者：
Ghosh, S. [1 ]
Kramer, B. C. [2 ]
Gasink, C. [2 ]
Jacobstein, D. [3 ]
Adedokun, O. J. [3 ]
Gao, L. -L. [3 ]
Rutgeerts, P. [4 ]
Sands, B. E. [5 ]
机构：
[1] Univ Birmingham, Birmingham, W Midlands, England
[2] Janssen Sci Affairs LLC, Horsham, PA USA
[3] Janssen Res & Dev LLC, Spring House, PA USA
[4] Univ Hosp Gasthuisberg, Leuven, Belgium
[5] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
来源：
JOURNAL OF CROHNS & COLITIS | 2019年 / 13卷
关键词：
D O I：
10.1093/ecco-jcc/jjy222.804
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P680
引用
收藏
页码：S459 / S460
页数：2
相关论文
共 50 条
  • [1] Long-Term Efficacy of Ustekinumab With and Without Concomitant Immunosuppressants for Crohn's Disease: Results From IM-UNITI Long-Term Extension Through 2 Years
    Sands, Bruce E.
    Kramer, Brian
    Gasink, Christopher
    Jacobstein, Douglas
    Adedokun, Omoniyi J.
    Gao, Long-Long
    Rutgeerts, Paul
    Ghosh, Subrata
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S329 - S329
  • [2] LONG TERM EFFICACY AND SAFETY OF USTEKINUMAB FOR CROHN'S DISEASE: RESULTS FROM IM-UNITI LONG-TERM EXTENSION THROUGH 2 YEARS
    Sandborn, W. J.
    Rutgeerts, P.
    Gasink, C.
    Jacobstein, D.
    Gao, L.
    Johanns, J.
    Sands, B.
    Hanauer, S.
    Targan, S.
    Ghosh, S.
    de Villiers, W. J. S.
    Colombel, J. F.
    Feagan, B. G.
    GUT, 2017, 66 : A22 - A22
  • [3] Long term efficacy and safety of Ustekinumab for Crohn's disease: results from IM-UNITI long-term extension through 2 years
    Sandborn, W.
    Rutgeerts, P.
    Gasink, C.
    Jacobstein, D.
    Gao, L. -L.
    Johanns, J.
    Sands, B.
    Hanauer, S. B.
    Targan, S.
    Ghosh, S.
    de Villiers, W. J. S.
    Colombel, J. -F.
    Feagan, B. G.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S6 - S6
  • [4] LONG-TERM EFFICACY AND SAFETY OF USTEKINUMAB FOR CROHN'S DISEASE: RESULTS FROM IM-UNITI LONG-TERM EXTENSION THROUGH TWO YEARS
    Sandborn, William J.
    Rutgeerts, Paul
    Gasink, Christopher
    Jacobstein, Douglas
    Gao, Long-Long
    Johanns, Jewel
    Sands, Bruce E.
    Hanauer, Stephen B.
    Targan, Stephan R.
    Ghosh, Subrata
    de Villiers, Willem J.
    Colombel, Jean Frederic
    Feagan, Brian G.
    GASTROENTEROLOGY, 2017, 152 (05) : S585 - S585
  • [5] Efficacy and Safety of Ustekinumab for Crohn's Disease: Results From IM-UNITI Long-Term Extension Through 3 Years
    Sandborn, William J.
    Rutgeerts, Paul
    Jacobstein, Douglas
    Gasink, Christopher
    Patel, Reese
    Zou, Bin
    Johanns, Jewel
    Sands, Bruce E.
    Hanauer, Stephen
    Targan, Stephan
    Ghosh, Subrata
    de Villiers, Willem
    Colombel, Jean-Frederic
    Feagan, Brian
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S345 - S346
  • [6] Efficacy and Safety of Ustekinumab for Crohn's Disease Through 5 Years: Final Results From the IM-UNITI Long-Term Extension
    Sandborn, William J.
    Rutgeerts, Paul
    Lynch, John
    Rebuck, Rory
    Wang, Yuhua
    Zou, Bin
    Gasink, Christopher
    Adedokun, Omoniyi
    Sands, Bruce E.
    Hanauer, Stephen
    Targan, Stephan
    Ghosh, Subrata
    de Villiers, Willem J. S.
    Colombel, Jean-Frederic
    Feagan, Brian G.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S323 - S324
  • [7] THE PHARMACOKINETICS AND IMMUNOGENICITY OF 5 YEARS OF TREATMENT WITH USTEKINUMAB: RESULTS FROM THE IM-UNITI LONG-TERM EXTENSION
    Adedokun, Omoniyi J.
    Sands, Bruce E.
    Ghosh, Subrata
    Lynch, John P.
    Zou, Bin
    Wang, Yuhua
    Gasink, Chritopher
    De Villiers, Willem J.
    Sandborn, William J.
    Feagan, Brian G.
    GASTROENTEROLOGY, 2021, 160 (06) : S354 - S354
  • [8] pharmacokinetics and immunogenicity of 5 years of treatment with ustekinumab (UST): results from the IM-UNITI long-term extension (LTE)
    Adedokun, Omoniyi J.
    Sands, Bruce E.
    Ghosh, Subrata
    Lynch, John
    Zou, Bin
    Wang, Yuhua
    Gasink, Christopher
    Devilliers, Willem J. S.
    Sandborn, William J.
    Feagan, Brian G.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 109 - 110
  • [9] Ustekinumab Maintained Clinically Meaningful Improvement in Health-Related Quality of Life in Patients With Moderate to Severe Crohn's Disease: Results From the IM-UNITI Long-Term Extension
    Sands, Bruce E.
    Han, Chenglong
    Gasink, Christopher
    Bin, Zou
    Stephen, Targan
    Sandborn, William J.
    Feagan, Brian G.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S404 - S404
  • [10] IMMUNOGENICITY OF USTEKINUMAB IN PATIENTS WITH CROHN'S DISEASE: RESULTS FROM THE IM-UNITI STUDY
    Sandborn, William J.
    Sands, Bruce E.
    Nussbaum, Jeannette
    Oortwijn, Alessandra
    Gasink, Christopher
    Jacobstein, Douglas
    Gao, Long-Long
    Adedokun, Omoniyi J.
    de Villiers, Willem J.
    Ghosh, Subrata
    GASTROENTEROLOGY, 2019, 156 (06) : S1097 - S1097
12345